These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Local hydrocortisone in Peyronie's disease. GHOSH S; GHOSH R; SEN S Br J Vener Dis; 1960 Sep; 36(3):186. PubMed ID: 13704956 [No Abstract] [Full Text] [Related]
48. A new concept in the treatment of Peyronie's disease. WHALEN WH J Urol; 1960 Jun; 83():851-2. PubMed ID: 13844250 [No Abstract] [Full Text] [Related]
49. A new concept in the treatment of Peyronie's disease. SCOTT WW; SCARDINO PL South Med J; 1948 Feb; 41(2):173-7. PubMed ID: 18898262 [No Abstract] [Full Text] [Related]
50. Peyronie's disease. REEVES RJ N C Med J; 1953 Jun; 14(6):245-6. PubMed ID: 13055111 [No Abstract] [Full Text] [Related]
56. [Therapy of Dupuytren's contracture]. WASSERBURGER K Strahlentherapie; 1956; 100(4):546-60. PubMed ID: 13360519 [No Abstract] [Full Text] [Related]
57. The treatment of Peyronie's disease with ACTH; preliminary report. SANJURJO LA Bol Asoc Med P R; 1952 Aug; 44(8):320-5. PubMed ID: 12977841 [No Abstract] [Full Text] [Related]
58. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study. Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734 [TBL] [Abstract][Full Text] [Related]
60. The use of cortisone in Dupuytren's contracture. RITCHEY SJ U S Armed Forces Med J; 1952 Jun; 3(6):811-8. PubMed ID: 14931773 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]